Roger Stoll

Roger G.
Stoll is currently the Director at BIOCOM.
Previously, he held positions such as President & Chief Executive Officer at Ohmeda, Inc. from 1991 to 1998, Executive Chairman at RespireRx Pharmaceuticals, Inc. from 2008 to 2012, and Director at St. Jude Medical LLC from 1991 to 2002.
He also served as a Director at Questcor Pharmaceuticals, Inc. from 1999 to 2005, Chelsea Therapeutics International Ltd. from 2008 to 2011, and Agensys, Inc. from 2003 to 2007.
Additionally, he was a Director at Chelsea Therapeutics, Inc. and the Pharmaceutical Research & Manufacturers of America.
He held the position of Director at Boc Group Plc from 1991 to 1998 and Executive Vice President-North America Region at Fresenius Medical Care Holdings, Inc. from 1998 to 2001.
Prior to that, he was EVP & GM-Worldwide Diagnostics Business Group at Bayer AG from 1986 to 1991 and President-Consumer Health Care Group at Miles, Inc. He started his career as President-American Critical Care Division at American Hospital Supply Corp.
Dr. Stoll obtained an undergraduate degree from Ferris State University (Michigan) and a doctorate degree from the University of Connecticut.